Amylyx ALS Drug Approval: Unexpected, Welcome, & Conditional
imagoRB/iStock via Getty Images Investment Thesis I last covered Amylyx (NASDAQ:AMLX) for Seeking Alpha earlier this month, just before the FDA’s Advisory Committee convened to discuss the upcoming Prescription Drug User Fee Act (“PDUFA”) date […]
